By vgreene, 7 January, 2021 Severe allergic reaction eg anaphylaxis to a previous dose of an mRNA COVID 19 vaccine or any of its components Action Do not vaccinate
By vgreene, 7 January, 2021 As part of the Phase 1a vaccination roll out some individuals in the U S have already begun receiving their 2nd dose of mRNA messenger ribonucleic acid COVID 19 vaccines The CDC s latest clinical guidance outlines the following vaccine contraindications t
By vgreene, 7 January, 2021 Interim analysis no difference in sustained recovery hospital discharge to home and remaining at home for 14 days and pulmonary ordinal outcome at Day 5
By vgreene, 7 January, 2021 Randomized double blind platform trial 314 hospitalized pts median age 61y w COVID 19 sx
By vgreene, 7 January, 2021 Study considerations preliminary report w limited f u enrollment stopped for futility platform protocol concomitant RDV and CS use
By vgreene, 7 January, 2021 KEY FINDINGS bamlanivimab RDV did not demonstrate efficacy in hospitalized pts w o end organ failure
By vgreene, 7 January, 2021 A Neutralizing Monoclonal Antibody for Hospitalized Patients With Covid 19
